Sapiens International Corporation NV
NASDAQ:SPNS

Watchlist Manager
Sapiens International Corporation NV Logo
Sapiens International Corporation NV
NASDAQ:SPNS
Watchlist
Price: 37.27 USD 0.05%
Market Cap: 2.1B USD
Have any thoughts about
Sapiens International Corporation NV?
Write Note

Sapiens International Corporation NV
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sapiens International Corporation NV
Other Current Liabilities Peer Comparison

Comparables:
WKME
N
NICE
CLBT
H
HLAN
P
PGY

Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Sapiens International Corporation NV
NASDAQ:SPNS
Other Current Liabilities
$31.9m
CAGR 3-Years
-9%
CAGR 5-Years
7%
CAGR 10-Years
11%
Walkme Ltd
NASDAQ:WKME
Other Current Liabilities
$110.7m
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
N
Nice Ltd
TASE:NICE
Other Current Liabilities
$342.4m
CAGR 3-Years
1%
CAGR 5-Years
4%
CAGR 10-Years
7%
Cellebrite DI Ltd
NASDAQ:CLBT
Other Current Liabilities
$200.3m
CAGR 3-Years
20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hilan Ltd
TASE:HLAN
Other Current Liabilities
â‚Ş114.9m
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
21%
P
Pagaya Technologies Ltd
NASDAQ:PGY
Other Current Liabilities
$18.7m
CAGR 3-Years
171%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Sapiens International Corporation NV's Other Current Liabilities?
Other Current Liabilities
31.9m USD

Based on the financial report for Jun 30, 2024, Sapiens International Corporation NV's Other Current Liabilities amounts to 31.9m USD.

What is Sapiens International Corporation NV's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
11%

Over the last year, the Other Current Liabilities growth was -12%. The average annual Other Current Liabilities growth rates for Sapiens International Corporation NV have been -9% over the past three years , 7% over the past five years , and 11% over the past ten years .

Back to Top